SEARCH

SEARCH BY CITATION

References

  • Ansell, J., Hirsh, J., Dalen, J., Bussey, H., Anderson, D., Poller, L., Jacobson, A., Deykin, D. & Matchar, D. (2001) Managing oral anticoagulant therapy. Chest, 119(Suppl.), 22S38S.
  • Azar, A.J., Cannegieter, S.C., Deckers, J.W., Briët, E., van Bergen, P.F., Jonker, J.J. & Rosendaal, F.R. (1996) Optimal intensity of oral anticoagulant therapy after myocardial infarction. Journal of the American College of Cardiology, 27, 13491355.
  • van Beek, E.J.R., Büller, H.R. & ten Cate, J.W. (1996) Epidemiology of venous thromboembolism. In: A Textbook of Vascular Medicine (ed. by J.E.Tooke & G.D.Lowe), pp. 471488. Arnold, London.
  • Cannegieter, S.C., Rosendaal, F.R., Wintzen, A.R., van der Meer, F.J.M., Vandenbroucke, J.P. & Briët, E. (1995) Optimal oral anticoagulant therapy in patients with mechanical heart valves. New England Journal of Medicine, 333, 1117.
  • Hirsh, J. (1991) Oral anticoagulant drugs. New England Journal of Medicine, 324, 18651875.
  • Hirsh, J., Dalen, J., Anderson, D.R., Poller, L., Bussey, H., Ansell, J. & Deykin, D. (2001) Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 119, 8S21S.
  • Hirsh, J., Fuster, V., Ansell, J. & Halperin, J.L. (2003) American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 1, 107, 16921711.
  • Hull, R.D., Hirsh, J., Jay, R., Carter, C., England, C., Gent, M., Turpie, A.G.G., McLoughlin, D., Dodd, P., Thomas, M., Raskob, G. & Ockelford, P. (1982) Different intensities of oral anticoagulant therapy in the treatment of proximal vein thrombosis. New England Journal of Medicine, 307, 16761681.
  • Hyers, T.M., Agnelli, G., Hull, R.D., Morris, T.A., Samara, M., Tapson, V. & Weg, J.G. (2001) Antithrombotic therapy for venous thromboembolic disease. Chest, 119(Suppl.), 176S193S.
  • Kearon, C., Ginsberg, J.S., Kovacs, M.J., Anderson, D.R., Wells, P., Julian, J.A., Mackinnon, B., Weitz, J.I., Crowther, M.A., Dolan, S., Turpie, A.G., Geerts, W., Solymoss, S., Van Nguyen, P., Demers, C., Kahn, S.R., Kassis, J., Rodger, M., Hambleton, J. & Gent, M. (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent thromboembolism. New England Journal of Medicine, 349, 631639.
  • Kleinbaum, D.G., Kupper, L.L., Muller, K.E. & Nizam, A. (1998) Applied Regression Analysis and Other Multivariable Methods, 3rd edn. Brooks/Cole Publishing Co., Pacific Grove, pp. 687709.
  • Levine, M.N., Raskob, G., Landefeld, S. & Kearon, C. (2001) Hemorrhagic complications of anticoagulant treatment. Chest, 119(Suppl.), 108S121S.
  • Ridker, P.M., Goldhaber, S.Z., Danielson, E., Rosenberg, Y., Eby, C.S., Deitcher, S.R., Cushman, M., Moll, S., Kessler, C.M., Elliott, C.G., Paulson, R., Wong, T., Bauer, K.A., Schwartz, B.A., Miletich, J.P., Bounameaux, H. & Glynn, R.J. (2003) Long term, low-intensity warfarin therapy for prevention of recurrent venous thromboembolism. New England Journal of Medicine, 348, 14251434.
  • Rosendaal, F.R. (1996) The Scylla and Charybdis of oral anticoagulant treatment. New England Journal of Medicine, 335, 587589.
  • Rosendaal, F.R., Cannegieter, S.C., van der Meer, F.J.M. & Briet, E. (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thrombosis and Haemostasis, 69, 236239.
  • Rosner, B. (1995) Fundamentals of Biostatistics, 4th edn. Wadsworth Publishing Co., Belmont, pp. 178181.
  • Rothman, K.J. & Greenland, S. (1998) Modern Epidemiology, 2nd edn. Lippincott-Raven Publishers, Philadelphia, PA, pp. 359432.
  • Sackett, D.L., Hayes, R.B., Guyatt, G.H. & Tugwell, P. (1991) Clinical Epidemiology. Little, Brown and Co., Boston, pp. 173185.
  • Schulman, S. & Lockner, D. (1985) Relationship between thromboembolic complications and intensity of treatment during long-term prophylaxis with oral anticoagulants following DVT. Thrombosis and Haemostasis, 53, 137140.
  • The European Atrial Fibrillation Trial Study Group (1995) Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. New England Journal of Medicine, 333, 510.